Procter & Gamble (PG)
(Delayed Data from NYSE)
$170.12 USD
-1.80 (-1.05%)
Updated Oct 3, 2024 04:00 PM ET
Pre-Market: $169.00 -1.12 (-0.66%) 9:14 AM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$170.12 USD
-1.80 (-1.05%)
Updated Oct 3, 2024 04:00 PM ET
Pre-Market: $169.00 -1.12 (-0.66%) 9:14 AM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Procter & Gamble (PG) Stock Moves -0.11%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Procter & Gamble (PG) closed at $169.06, indicating a -0.11% shift from the previous trading day.
Is Most-Watched Stock Procter & Gamble Company (The) (PG) Worth Betting on Now?
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Procter & Gamble (PG) Trades Near 52-Week High: Should You Buy?
by Rajani Lohia
Procter & Gamble (PG) witnesses consistent growth, with the stock creating new 52-week highs in less than two months.
Procter & Gamble (PG) Stock Moves -0.01%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) concluded the recent trading session at $170.15, signifying a -0.01% move from its prior day's close.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Procter & Gamble (PG) Slips Post Q4 Earnings: ETFs in Focus
by Sanghamitra Saha
Procter & Gamble Company (PG) came up with mixed results in Q4 earnings. The result puts these ETFs in focus.
Company News for Jul 31, 2024
by Zacks Equity Research
Companies in The News Are: PFE, PG, SFM, ADM
Procter & Gamble (PG) Q4 Earnings Beat, Stock Down on Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q4 earnings reflect gains from improved volume and pricing, offset by adverse currency rates and higher costs, which impact its operating margin.
Case-Shiller Home Prices Tick in Higher
by Zacks Equity Research
Case-Shiller Home Prices Tick in Higher.
Pre-Markets Flat Again Ahead of Fed Report Tomorrow
by Mark Vickery
Market participants not look hungry to act until it understands more about the Fed's thinking.
P&G (PG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) Q4 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 2.19% and 0.91%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Awaits for Pilgrim's Pride's (PPC) Q2 Earnings Release?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 performance will reflect gains from robust market momentum and improved efficiency. However, an elevated cost environment is a hurdle.
Service Corporation (SCI) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2024 performance will likely reflect gains from strength in the Cemetery segment. However, a rising interest rate environment poses a threat.
Can Clorox's (CLX) Pricing & Cost-Saving Plan Aid Q4 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from pricing strategies and cost-saving initiatives, as well as progress on the IGNITE strategy, amid high SG&A expenses.
Market Awaits JOLTS Numbers Due Tuesday
by Zacks Equity Research
Market Awaits JOLTS Numbers Due Tuesday.
Big Numbers Ahead: Q2 Earnings, Fed Meeting, Jobs Week
by Mark Vickery
Jobs Week, Fed Week and the busiest week of Q2 earnings so far await us.
Hershey's (HSY) Q2 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Hershey's (HSY) Q2 results are likely to reflect gains from brand strength, but high commodity costs, increased selling, marketing and administrative expenses and currency volatility are concerns.
Is Procter & Gamble (PG) a Smart Investment Pre-Q4 Earnings?
by Rajani Lohia
While P&G's (PG) strong financial performance and strategic initiatives provide a solid foundation for growth in Q4, the external risks justify a neutral stance on its investment potential.
Colgate-Palmolive (CL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.60% and 0.93%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Clorox (CLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Consumer Staples Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.